1.The characteristic of causative organisms and outcomes of peritonitis in younger and elderly peritoneal dialysis patients
Zengsi WANG ; Yanmin ZHANG ; Fei XIONG ; Hongbo LI ; Yanqiong DING ; Yihua GAO
Chinese Journal of Nephrology 2015;31(4):241-245
Objective To provide guide for prevention and cure of peritonitis in peritoneal dialysis(PD) by comparing the causative organisms and clinical outcome of PD related peritonitis in younger and elderly patients in our center.Methods All patients who developed PD related peritonitis between January 2006 and December 2013 in Wuhan NO.1 hospital were included.According to their age,episodes were divided into younger patients group (< 65 years) and elderly patients group (≥65 years).The microbiology and clinical outcome of PD related peritonitis were compared,and the related risk factors of the treatment failure were analyzed.Results Three hundred and sixty-six episodes of peritonitis occurred in 258 patients during the study period.The overall rate of peritonitis was 1 episode in 76.8 patient-months.Elderly patients had higher incidence of peritonitis (1 episode every 56.4 months vs 1 episode every 88.7 months,P=0.001),higher incidence of fungus infection (9.6% vs 3.9%,P=0.026) and higher mortality (46.2% vs 14.0%,P=0.001) than that in younger patients.Cox regression analysis showed that longer duration of PD treatment and fungal peritonitis were both risk factors of the treatment failure.Conclusion Elderly patients had higher incidence of peritonitis,higher incidence of fungus infection and higher PD-related mortality than younger patients.
2.Analysis of construction strategy of user-oriented institutional repository under the background of evaluation of scientific and technological impact
Jin XU ; Yanqiong LI ; Xue WANG ; Fang WANG ; Jiajia LI ; Lu LI ; Rurong DING
Chinese Journal of Medical Science Research Management 2020;33(2):81-85
Objective:Guiding hospitals to strengthen the emphasis on clinical medical research, promote hospital discipline construction, to improve the quality of medical services and clinical innovation capacities.Methods:Starting from different user groups, combines the experience of the knowledge base of the library construction institution of Grade-A Tertiary Hospital and the cooperation experience with various functional departments, this paper analyzes the functional structure of the institutional repository according to the problems faced in the actual work to explore the difficulties during the construction process.Results:The construction of the Institutional Repository of hospitals for different users is imminent. In addition to the use of Institutional Repository to improve the utilization of intelligence and information resources, the construction of institutional repository on the evaluation of science and technology influence can also promote the development of hospital disciplines.Conclusions:A solution method is proposed, based on the background of scientific and technological influence evaluation, the future construction direction of the institutional repository.
3.Systematic Review on Safety of Chinese Medicines Combined with Tripterygium wilfordii Preparations in Treatment of Rheumatoid Arthritis and Exploration on Underlying Network Regulatory Mechanisms of Enhancing Efficacy and Reducing Toxicity
Yi ZHANG ; Xiaoyue WANG ; Zihe DING ; Wenjia CHEN ; Yudong LIU ; Na LIN ; Yanqiong ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(5):1-8
ObjectiveTo systematically evaluate the safety of Chinese medicines combined with Tripterygium wilfordii polyglycoside tablets/Tripterygium wilfordii tablets (TWPT/TWT) in the treatment of rheumatoid arthritis (RA), and to explore the network regulatory mechanisms of enhancing efficacy and reducing toxicity of commonly used combination regimes. MethodThe literature involving the adverse reactions of TWPT/TWT in treating RA was searched and collected from three Chinese databases (CNKI, Wanfang Data, VIP) and three English databases (PubMed, Cochrane Library, Embase) from the inception of the databases to July 2021. All studies were assessed by the Cochrane risk of bias tool, and the data were extracted and analyzed by Stata 15.0. Furthermore, Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine 2.0 (TCMIP v2.0,